07.13.10
Sabinsa Corporation, East Windsor, NJ, has received Product Information (PI) numbers for ForsLean 10% and 20% from Australia’s TGA (Therapeutic Goods Administration), a division of the Australian Government Department of Health and Ageing. Obtaining the PI numbers opens the door for ForsLean to enter the Australian market. The numbers are: 11628 Sabinsa Coleus Forslean (1) 26/04/2005, 107073 Sabinsa Coleus forskohlii extract 10%. Product Information (PI) provides health professionals with a summary of the essential scientific information about a therapeutic product, which requires information relating to its safe and effective use. Product Information documents are provided to and reviewed by the TGA as part of the approval process before a therapeutic product can be made available in Australia.